Detalhe da pesquisa
1.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560813
2.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Eur J Haematol
; 111(3): 485-490, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381686
3.
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood Adv
; 6(18): 5395-5402, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675590